Back to Market返回行情

EVH Evolent Health, Inc.

USHealthcare
$5.63+0.54%ClosedMarket Cap: $633.3M

As of 2026-07-09 16:00

Why EVH matters now

Evolent Health, Inc. (EVH) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.63 with +0.54% on the session and $633.3M in market capitalization; recent performance reads 1-month +15.42% and YTD +12.25%.

The latest financial table shown here is Q1 2026, with revenue of $496.2M, net income of $-26.6M, and EPS of $-0.24. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 0.3%.

The latest indexable market news headline is "Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026" from PRNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $6.00; recent insider activity includes Barbarosh Craig A. filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.27

P/S

0.27

EV/EBITDA

-4.21

DCF Value

$-109.63

FCF Yield

0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

14.1%

Operating Margin

-0.9%

Net Margin

-26.3%

ROE

-77.9%

ROA

-26.4%

ROIC

-1.1%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$496.2M$-26.6M$-0.24
Q4 2025$468.7M$-429.1M$-3.76
FY 2025$1.88B$-534.5M$-5.07
Q3 2025$479.5M$-20.9M$-0.24

Analyst Ratings

Consensus

Buy

Target (Consensus)

$6.38

Target (Median)

$6.00

Target Range

$3.50 - $10.00

Strong Buy: 4Buy: 10Hold: 2Sell: 0Strong Sell: 0
Truist SecuritiesBuy
2026-06-12
CitigroupBuy
2026-05-15
Canaccord GenuityBuy
2026-05-12
NeedhamBuy
2026-05-07
OppenheimerOutperform
2026-03-02

Trading Activity

Insider Trades

Barbarosh Craig A.director
Sell2026-06-08
Springstubb Brendan Bdirector
Sell2026-06-08
Smith Jill D.director
Sell2026-06-08
KECK KIMdirector
Sell2026-06-08
Jelinek Richard Mdirector
Sell2026-06-08

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

Beta

0.83

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.